Sorry Jebco, been in a meeting. the indicators are not just technical but, to be honest, based somewhat on historical patterns and yes a gut feeling. They are coming up toward 2nd qtr reporting date and historically we have seen an uptick in pr in the week or so prior. It is this uptick, and it depends what the pr is, that I feel will jump the stock to .023-.025 area give or take 7%. after the report which i feel will be flat in rev. the stock will dip back down under .02 again. Now, this will be the critically time for the next month. If FDA looks like it won't happen for another 90 days, or if they don't get someone to help them uplist we could see a dramatic drop to even .009.
the company has to make the right moves in September. If they get the uplist done we are going back up to .035 or so and with any hint of strong jump in rev we could get to .046. After that, alot depends on FDA. No FDA, then we will have to depend on strictly international sales or hope of buyout, with FDA I see us at .16 to even .18 in a year(some people feel much higher than this even)
Bottom line is we need to start being mentioned weekly on the hot list of stocks to get the buyers back.
Short term people have several times to make money in the next six months. I myself am still accumulating but will probably play both. I think I have a good feel for this one and I am trusting a lot to my gut along with the technicals. My advice is, short time play the technicals, long term play both. Do lots of reading in the next qtr. report. but most of all understand that this is just my opinion and I look forward to hearing yours and everyone elses.
Now to the next meeting.
News 
Market Data 
Discover 
AI
